Systemic sclerosis (SSc), known as scleroderma, is a complex autoimmune
disorder marked by skin and internal organ fibrosis, vasculopathy, and immune
system abnormalities. This chronic condition presents diverse clinical features,
from skin thickening to serious organ involvement affecting the heart, lungs,
gastrointestinal tract, and kidneys. Pathogenesis involves immune dysregulation,
endothelial dysfunction, and fibroblast activation, which leads to excess collagen
deposition. While genetic, environmental, and immunological factors contribute
to its development, the exact cause remains unknown. Despite progress in
understanding SSc pathophysiology and treatment, the disease significantly
challenges patients and healthcare providers due to its diverse manifestations,
particularly from pulmonary and cardiovascular complications. Additionally, SSc
has the highest mortality rate among rheumatic diseases. Beyond physical
symptoms, SSc profoundly impacts mental health, with patients frequently
experiencing depression, anxiety, sexual dysfunction, sleep disturbances, and
self-image issues. This review explores the relationship between SSc and mental
health, highlighting the prevalence of psychiatric symptoms, psychosocial
factors, and their implications for disease management. By examining current
literature, this review aims to enhance understanding of SSc's multifaceted nature
and inform comprehensive care strategies to meet the holistic needs of patients. It
underscores the importance of integrating mental health evaluations into routine
SSc management and developing targeted interventions to improve
psychological well-being and overall quality of life for SSc patients.
Keywords: Systemic Sclerosis; Scleroderma; mental health; depression; anxiety
